Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years old
- People who have been diagnosed with primary peripheral lung cancer (a specific type of lung cancer located toward the outer part of the lung), confirmed by a tissue test (pathology), at an early stage (called stage IA, T1N0M0) — this includes people who have developed a new or separate lung cancer after previous surgery
- People whose lung tumour has been assessed as suitable for treatment using both CT-guided and bronchoscopy-guided ablation (procedures that use imaging and a small camera to guide targeted treatment)
- People who are not suitable for surgery, or who have chosen not to have surgery, and who agree to receive ablation as the first treatment and have signed a consent form
Who may not be able to join:
- People with a low platelet count, serious bleeding problems, or blood clotting disorders that cannot be corrected quickly
- People with severe scarring of the lung tissue (pulmonary fibrosis) or high blood pressure in the lung's blood vessels (pulmonary arterial hypertension)
- People who have an active infection or radiation-related inflammation near the tumour, an uncontrolled skin infection at the planned treatment site, a body-wide infection, or a high fever above 38.5°C
- People with serious problems affecting the liver, kidneys, heart, lungs, or brain, or with severe anaemia, dehydration, or significant nutritional problems that cannot be corrected or improved quickly
- People with pleural effusion (fluid around the lungs) that is not well controlled
- People who have been taking blood-thinning or anti-platelet medications (with some exceptions such as dabigatran or rivaroxaban) and have not stopped taking them at least 5–7 days before the procedure
- People with a physical functioning score above 2 on a standard scale used to measure how much a person's illness affects their daily abilities (confirm with trial site)
- People who have another cancer that has spread widely through the body, with an expected survival of less than 6 months
- People with a history of episodic (recurring) psychosis (serious mental health episodes)
- People who are pregnant, or who plan to become pregnant during the study period
- People who have taken part in, or are currently taking part in, another clinical trial within the past 30 days
- People who have any other condition that the trial investigators consider unsuitable for participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jiayuan Sun, PhD, Shanghai Chest Hospital
Phone: +86-021-22200000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete ablation rate at 12 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.